BASELINE REMNANT CHOLESTEROL MODIFIES THE EFFECT OF INTENSIVE BLOOD PRESSURE CONTROL ON CARDIOVASCULAR OUTCOMES IN PATIENTS WITH TYPE 2 DIABETES: THE ACCORD-BP TRIAL.
- Resource Type
- Abstract
- Source
- Journal of Hypertension; Jun2023 Suppl3, Vol. 41, pe200-e200, 1p
- Subject
- Language
- ISSN
- 02636352